Identifying and characterizing a novel activating mutation of the FLT3 tyrosine kinase in AML
Jingrui Jiang, J. Guillermo Paez, Jeffrey C. Lee et al. · Blood · 2004
The FLT3 receptor is activated by juxtamembrane insertion mutations and by activation loop point mutations in patients with acute myeloid leukemia (AML). In a systematic tyrosine kinase gene exon resequencing study, 21 of 24 FLT3 exons were sequenced in samples from 53 patients with AML, 9 patients with acute lymphoblastic leukemia (ALL), and 3 patients with myelodysplasia samples. Three patients had novel point mutations at residue N841 that resulted in a change to isoleucine in 2 samples and to tyrosine in 1 sample. Introduction of FLT3-N841I cDNA into Ba/F3 cells led to interleukin-3 (IL-3)-independent proliferation, receptor phosphorylation, and constitutive activation of signal transducer and activator of transcription 5 (STAT5) and extracellular regulatory kinase (ERK), suggesting that the N841I mutation confers constitutive activity to the receptor. An FLT3 inhibitor (PKC412) inhibited the growth of Ba/F3-FLT3N841I cells (IC(50) 10 nM), but not of wild-type Ba/F3 cells cultured with IL-3. PKC412 also reduced tyrosine phosphorylation of the mutant receptor and inhibited STAT5 phosphorylation. Examination of the FLT3 autoinhibited structure showed that N841 is the key residue in a hydrogen-bonding network that likely stabilizes the activation loop. These results suggest that mutations at N841 represent a significant new activating mutation in patients with AML and that patients with such mutations may respond to small-molecule FLT3 inhibitors such as PKC412.
Cited by 85 works. doi:10.1182/blood-2004-02-0712
Authors
- Jingrui Jiang
- J. Guillermo Paez
- Jeffrey C. Lee
- Ronghai Bo
- Richard Maury Stone
- Daniel J. DeAngelo
- Ilene A Galinsky
- Brian Matthew Wolpin
- Anna T Jonasova
- Paula K. Herman
- Edward A. Fox
- Titus J. Boggon
- Michael J. Eck
- Ellen Weisberg
- James D. Griffin
- D. Gary Gilliland
- Matthew M. Meyerson
- William R. Sellers
References
- Improved methods for building protein models in electron density maps and the location of errors in these models
- Primer3 on the WWW for General Users and for Biologist Programmers
- SETOR: Hardware-lighted three-dimensional solid model representations of macromolecules
- Internal tandem duplication of the flt3 gene found in acute myeloid leukemia.
- Activating mutation of D835 within the activation loop of FLT3 in human hematologic malignancies
- The roles of FLT3 in hematopoiesis and leukemia
- Signaling Through the Hematopoietic Cytokine Receptors
- Analysis of FLT3 length mutations in 1003 patients with acute myeloid leukemia: correlation to cytogenetics, FAB subtype, and prognosis in the AMLCG study and usefulness as a marker for the detection of minimal residual disease
- The role of FLT3 in haematopoietic malignancies
- Inhibition of mutant FLT3 receptors in leukemia cells by the small molecule tyrosine kinase inhibitor PKC412